Health In Tech Inc. has announced new compensation terms for its Chief Executive Officer, Tim Johnson, and Chief Financial Officer, Linlin (Julia) Qian. Both executives have been granted 80,000 shares of restricted stock each, tied to the progression of a newly launched initiative. The shares will vest in three equal portions: the first third will vest monthly over a year starting from the signing of a letter of intent or memorandum of understanding; the second third will vest monthly over a year following the initiative's entry into proof-of-concept or beta launch; and the final third will vest monthly over a year after the initiative's full commercial launch. The restricted stock awards are issued under the company's Equity Incentive Plan.